Document is current
Any future updates will be listed below
-
Authors
van den Oever, F. J. https://orcid.org/0000-0001-9537-503X
Vasbinder, E. C.
Schrama, Y. C.
van Gelder, T.
van den Bemt, P. M. L. A.
Hugtenburg, J. G.
-
Funding
Funding for this research was provided by:
Nierstichting (22OP+056)
- License Information
-
More Information
Article History
Received: 12 April 2025
Accepted: 31 July 2025
First Online: 26 September 2025
Declarations
:
: In the last year, TvG has received lecture fees and consulting fees from Roche Diagnostics, Thermo Fisher, Vitaeris, Otsuka, CSL Vifor, Astellas and Aurinia Pharma. In all cases money has been transferred to hospital accounts, and none has been paid to his personal bank accounts. TvG does not have employment or stock ownership at any of these companies, and neither does he have patents or patent applications. No competing interests are present for the rest of the authors. This research was partly funded by the Dutch Kidney Foundation (grant identification number 22OP + 056).
: The study was conducted according to the principles of the Declaration of Helsinki (October 2013). The study was assessed by the accredited Medical Ethics Committee (METC) of MEC-U (Medical Ethical Committee Utrecht) and deemed not to be subject to the Medical Research Involving Human Subjects Act (WMO), approval letter W21.142.
: All patients provided written informed consent.
